The management of psychosis in movement disorder patients.
Psychosis may be seen with several movement disorders. As pharmacological treatments can sometimes worsen movement disorders, psychosis in these situations can be complex for clinicians to manage. This review covers the management of psychosis in three different movement disorders: Parkinson's disease, dementia with Lewy bodies and Huntington's disease.
Chou
Kelvin L
KL
Department of Clinical Neurosciences, Warren Alpert Medical School of Brown University, Providence, RI, USA. Kelvin_Chou@brown.edu
Borek
Leora L
LL
Friedman
Joseph H
JH
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003024:Clozapine / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy* / Q000523:psychology; D020961:Lewy Body Disease / Q000188:drug therapy* / Q000523:psychology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology; D010353:Patient Education as Topic; D011618:Psychotic Disorders / Q000188:drug therapy*; D018967:Risperidone / Q000627:therapeutic use
D014150:Antipsychotic Agents; D003024:Clozapine; D006220:Haloperidol; D018967:Risperidone